Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cysC protein, E coli

Known as: APS kinase, E coli 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND Post-myocardial infarction (MI) patients have a doubled rate of kidney function decline compared with the general… Expand
2018
2018
Purpose: Kidney injury molecule (KIM)-1, a transmembrane-tubular protein, is excreted in the urine within 12 h of the initial… Expand
  • table 1
  • figure 2
  • figure 3
2016
2016
Introduction La cystatine C (CysC) est un biomarqueur pressenti pour remplacer la creatinine dans l’evaluation de la fonction… Expand
2016
2016
Background: Large artery atherosclerosis is a major cause of ischemic stroke worldwide. Differential biomarker profiles… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Review
2015
Review
2015
The aim of this study is to determine which indicator of chronic kidney disease most closely correlates with 10-year Framingham… Expand
  • table 1
  • table 2
  • figure 1
  • figure 1
2015
2015
BACKGROUND The aim of this study was to investigate the relationship between serum CysC levels and high blood pressure (HBP) and… Expand
2014
2014
目的:探讨 CysC 水平用于急性心力衰竭预后的评定价值,为心力衰竭病情发展提供参考依据。方法选取2013年1月-2014年1月收治的急性心力衰竭患者60例作为心力衰竭组,按 NYHA 进行心功能分级,另选取30… Expand
Highly Cited
2013
Highly Cited
2013
Chronic kidney disease risk factors may associate with the estimated glomerular filtration rate (eGFR) differently than with the… Expand
  • figure 1
  • figure 2
  • figure 3
2013
2013
BackgroundRenal inulin clearance is the gold standard for evaluation of kidney function, but is compromised by problems of… Expand
  • figure 1
  • table 1
  • figure 4
  • figure 2
  • figure 3
2011
2011
BACKGROUND AND OBJECTIVES Cystatin C (CysC) is a promising marker of GFR. Several equations have been derived to estimate GFR… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3